Ειδήσεις: CLINICAL TRIAL | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

24/03 21:35 gizmodo.com

Finally, Some Good News in the Fight Against Lyme Disease

Lyme disease vaccine efficacy clinical trial tick-borne illness public health

24/03 16:43 yahoo.com

TD Cowen Upgrades IQVIA (IQV) to Buy and Raises Price Target to $213

TD Cowen IQVIA Buy rating price target $213 data analytics

24/03 14:51 investing.com

Ocugen stock falls 5% despite positive gene therapy trial data

Ocugen gene therapy biotech stock decline clinical trial investor sentiment

23/03 16:59 investing.com

Insmed shares rise as Arikayce trial data point to larger market opportunity

Insmed Arikayce clinical trial market opportunity biotech shares

23/03 13:41 investing.com

Apogee Therapeutics stock jumps on positive trial data

Apogee Therapeutics stock jump positive trial data biotech clinical trial investor confidence

23/03 12:30 statnews.com

STAT+: Apogee Therapeutics data show long-acting eczema drug induced relief with less frequent injections

Apogee Therapeutics zumilokibart eczema long‑acting therapy atopic dermatitis EASI‑75

21/03 14:04 sciencedaily.com

New pill cuts “bad” cholesterol by 60% in major trial

Enlicitide LDL cholesterol oral medication statins cardiovascular risk cholesterol management

20/03 01:19 statnews.com

Drug development is booming in China. Should the U.S. view it as a threat or an opportunity?

China CAR‑T biotech drug development U.S. innovation clinical trials

19/03 15:29 forbes.com

Patients On Lilly’s Experimental Diabetes Drug Lost 15% Of Their Weight And Lowered Blood Sugar, Company Says

Lilly experimental diabetes drug weight loss blood sugar reduction clinical trial type 2 diabetes

19/03 15:29 forbes.com

Patients On Lilly’s Experimental Diabetes Drug Lost 15% Of Their Weight And Lowered Blood Sugar, Company Says

Lilly experimental diabetes drug weight loss blood sugar reduction clinical trial type 2 diabetes

Loading...